ASERTI Pharmaceutical

Eliminating Problem Proteins at their Source

ASERTI Pharmaceutical is pioneering SERTI-based therapeutics that degrade harmful proteins before they ever reach their destination unlocking a bold new era in precision medicine.

ASERTI Pharmaceutical

Problems & Opportunity

Treating devastating diseases at the protein level

About ASERTI

Revolutionizing Targeted Protein Degradation

ASERTI is pioneering therapeutic innovation with a bold new class of targeted protein degradation drugs—SERTIs, or Selective Endoplasmic Reticulum Translocation Inhibitors.

Our mission is simple: To alleviate diseases by selectively eliminating dysfunctional proteins at their source.

ASERTI’s Advantages

Combining AI-Enabled Drug Design with Breakthrough Screening

ASERTI’s AI-enabled drug design platform empowers rapid, efficient SERTI drug design.

A novel process for rapidly screening SERTI compounds further reduces the risk, cost, and timeline for SERTI drug development, accelerating the arrival of the next wave of medical miracles.

Collaboration is the Catalyst

ASERTI’s mission to pioneer SERTI therapeutics depends on bold, strategic partnerships. From lab benches to boardrooms, every partner plays a vital role in advancing the science and delivering medical miracles.

Partner Labs & Research Institutions

Our research partners bring essential facilities, tools, and expertise that allow us to rapidly prototype, test, and validate SERTI molecules. Their work fuels our progress from hypothesis to proof—and helps us move faster toward clinical translation.

Investors & Funding Partners

Our investors don’t just back our mission—they amplify it. Strategic funding enables us to attract top talent, scale our platforms, and bring life-changing therapies to market sooner.

Suppliers & Technology Providers

From compound synthesis to in vitro testing tools, our supply and technology partners ensure we have the resources to move efficiently. Their reliability and innovation are essential to every breakthrough we make.
Contact Us

Thanks for Your Interest!

Accessibility Toolbar